The global skin antiseptic products market was valued at USD 5.9 billion in 2022 and is expected to impel at a CAGR of 6.9% by 2030. Demand for skin antiseptic products market is increasing due to the rising prevalence of hospital acquired diseases or hospital acquired infection (HAI) and increasing use of surgical units and endoscope reprocesses. Increasing cases of hospital-acquired infections due to lack of sanitation & precaution are among the major factors contributing to market growth. According to the Centers for Disease Control and Prevention (CDC), about 1 in 25 hospital patients has at least one healthcare-associated infection, on any given day. The use of antiseptics generally provides protection against contamination and lowers the risk of hospital-acquired infections. Moreover, it prevents bacteria, viruses, or other microbes that cause diseases from entering a patient’s body. Thus, such solutions are widely required in hospitals to maintain proper hygiene & sanitation, as well as to lower the risk of hospital-acquired infections. Therefore, this factor is expected to propel the market growth during the forecast period.
The growing rate of endoscopy is also expected to increase the risk of acquiring hospital-acquired infections. The most common types of infections that can occur after endoscopy include:
Gastrointestinal infections: This type of infection can occur if the endoscope is not properly cleaned and disinfected after and before use. The most common bacteria that cause gastrointestinal infections are Escherichia coli, Salmonella, and Clostridium difficile.
Respiratory infections: If the endoscope is not properly cleaned and disinfected, it can also transmit respiratory infections such as pneumonia or tuberculosis.
Urinary tract infections: If the endoscope is used to examine the urinary tract, there is a risk of transmitting urinary tract infections if the equipment is not properly cleaned and disinfected.
To prevent hospital-acquired infections due to endoscopy, hospitals, and medical facilities should follow strict protocols for cleaning and disinfecting the endoscopes and other equipment used during the procedure. Healthcare professionals should also adhere to strict hand hygiene practices and use appropriate antiseptic & disinfectant solutions to prevent the transmission of infections.
The COVID-19 pandemic has had a significant impact on the market for skin antiseptics, which are used to disinfect the skin before invasive procedures or surgery. With the increased emphasis on infection control and prevention during the pandemic, the demand for skin antiseptics has skyrocketed, leading to shortages and price increases. An increase in the number of vaccinations is leading to an increase in the use of injections
Moreover, to cope with the increasing demand, companies in the market are entering into strategic initiatives, such as product launches, geographical expansion, mergers, acquisitions, and partnerships. For instance, in February 2021, Avrio Health announced the launch of Betadine, Similarly, to increase its reach, Cardinal Health, announced the addition of a new distribution center in Columbus., Ohio. Thus, the above-mentioned factors are anticipated to propel the skin antiseptic product market during the post-pandemic period.
The alcohol segment dominated the skin antiseptic product market in 2022 owing to increasing usage for pre-injection and pre-operative skin preparation. Furthermore, the growing demand for alcohol bases to be used in combination with other formulations, such as iodine and chlorhexidine is fueling the segment growth. In addition, alcohol skin antiseptic products comprise antiseptic agents, such as isopropyl or ethyl, which are effective against numerous microbes.
Octenidine skin antiseptic products market is anticipated to witness the fastest growth of 7.5% over the forecast period. It is an internal substitute for chlorhexidine and iodine antiseptic products. Moreover, in countries such as the U.S., the FDA has restricted the use of chlorhexidine & iodine. This may aid in the growth of the market for alternatives such as octenidine.
Based on type, solutions were the highest revenue-generating segment with a market share of 48.4% in 2022. This can be accredited to the high prevalence of hospital acquired infections & SSIs and the easy availability of numerous solutions in the market. Moreover, growing awareness and increasing applications of antiseptic solutions in pre-operation and pre-injection skin preparation are impelling the market. Antiseptic solutions significantly reduce the contamination risk and transmission of infection.
In addition, rising cases of hospital acquired infections have led to an increase in the usage of antiseptics for surgeries. For instance, as per NCBI, approximately, 1.7 Million hospitalization lead to hospital acquired infections annually. Similarly, according to an article by European Center for Disease Prevention and Control in 2018, around 8.9 Million HAIs were estimated to arise every year in the European long-term care facility and hospitals. Therefore, due to the above-mentioned factors, the solution segment is predicted to witness significant growth over the forecast period.
However, the wipes segment is anticipated to witness the fastest growth of CAGR of 7.1% over the forecast period. Wipes are easy to use and help in film and tape adhesion. Furthermore, wipes are extremely effective for wound application, since they completely clean the wound area, leaving behind no residue.
The injection segment dominated the skin antiseptic products market in 2022 with a market share of 72.2% and is anticipated to witness the fastest growth over the forecast period. The growth of the segment is attributable to the increasing use of joint injections for extracting fluid from swollen joints for injecting medicines.
The growing geriatric population and individuals suffering from joint injuries and sports-related wounds respectively are the primary users of the injections. Furthermore, joint injections carrying zero side effects are gaining popularity among patients, which is again expected to expand the market considerably during the forecast period.
The surgeries segment is anticipated to witness a significant growth rate of 5.5% over the forecast period. The growth rate can be credited to the rising number of surgical cases globally. For instance, as per the Aesthetics Society, 252,022 breast augmentation, 296,601 liposuctions, and 163,073 abdominoplasty surgeries were recorded in the year 2020.
The hospital segment dominated the skin antiseptic products market in 2022 with a market share of 48.5%. Skin antiseptics are used in hospitals to prevent infections and maintain a sterile environment in various medical procedures and surgeries. Skin antiseptics are used in hospitals for various purposes, including preoperative skin preparation, catheter insertion, wound care, and intravenous line placement, among others. The use of skin antiseptics in hospitals is essential to prevent infections and maintain patient safety.
The demand for skin antiseptics in hospitals is expected to increase due to the growing number of surgical procedures and the need for infection control measures. Moreover, the increasing prevalence of hospital-acquired infections is expected to drive the demand for skin antiseptics in the hospital segment. Therefore, manufacturers of skin antiseptics are focusing on developing products that are safe and effective for use in hospitals. They are also investing in research and development activities to improve the efficacy of skin antiseptics and meet the increasing demand for these products in hospitals.
The outpatient facilities segment is anticipated to witness a significant growth rate of 7.5% over the forecast period. These facilities include clinics, ambulatory surgery centers, urgent care centers, and diagnostic centers. The growing demand for outpatient services, coupled with the increasing awareness of the importance of infection control, is expected to drive the growth of the outpatient facilities segment in the skin antiseptic market. The increasing prevalence of chronic diseases, the aging population, and the rise in healthcare expenditure are also expected to boost the demand for outpatient services.
North America dominated in 2022 and is expected to dominate the market over the forecast period. The rising number of surgeries in this region is one of the major drivers positively impacting the market growth. The pre-operative skin preparation is one of the essential steps adopted by surgeons before surgeries. Thus the demand for skin-antiseptics products is anticipated to rise with the increasing rate of surgeries.
Asia-Pacific is expected to witness the fastest growth rate of 7.4% over the forecast period. Increasing healthcare expenditure by the public and private sectors is one of the major driving factors for the market. Such a scenario is anticipated to encourage several major and local players to enter the market owing to which market growth is expected.
Key players have taken strategic initiatives, such as partnership, merger& acquisition, and product launch, to sustain in the market. For instance, in February 2019, Schülke & Mayr signed a distribution agreement with DKSH, one of the leading market expansion service providers. Under this agreement, DKSH will distribute and market a wide range of Schülke’s disinfectant products in China. Some of the prominent players in the global skin antiseptic products market include:
Sage Products LLC
B.Braun Melsungen AG
Schulke & Mayr GmbH
Smith & Nephew
Market size value in 2023
USD 5.1 billion
Revenue forecast in 2030
USD 8.2 billion
CAGR of 6.9% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD million/billion and CAGR from 2023 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Formulation, type, application, end-use, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Sweden; Denmark; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
3M; EcoLab; BD; Sage Products LLC; B.Braun Melsungen AG; Schulke & Mayr GmbH; Cardinal Health; Smith & Nephew; Avrio Health; Microgen.
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at a global, regional, and country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented skin antiseptic products market report based on formulation, type, application, end-use, and region:
Formulation Outlook (Revenue USD Million; 2018 - 2030)
Type Outlook (Revenue USD Million; 2018 - 2030)
Application Outlook (Revenue USD Million; 2018 - 2030)
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Research & Manufacturing
Regional Outlook (Revenue USD Million; 2018 - 2030)
Middle East and Africa
b. The global skin antiseptic products market size was estimated at USD 5.9 billion in 2022 and is expected to reach USD 5.1 billion in 2023
b. The global skin antiseptic products market is expected to grow at a compound annual growth rate of 6.9% from 2023 to 2030 and is projected to reach 8.2 billion in 2030.
b. The market was dominated by the alcohol segment in 2022 with a market share of 25.5%. Alcohols are the most commonly used antiseptics for pre-operative and pre-injection skin preparation.
b. Some key players operating in the skin antiseptic products market include BD, 3M, EcoLab, Schulke & Mayr GmbH, Sage Products LLC, J, and B.Braun Melsungen AG.
b. Key factors that are driving the skin antiseptic products market growth include the increasing prevalence of hospital-acquired diseases and increasing the use of endoscope reprocesses and surgical units are anticipated to drive the market growth.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."